NIAID Study Shows Low-Dose Marburg Vaccine Effective in Macaques Medical Countermeasures August 25, 2023 …
Imunon Enters into CRADA for Preclinical Studies of PlaCCine Modality in Preventive Vaccines Against Lassa Virus Industry News August 24, 2023 …
Project NextGen: HHS Awards $1.4B for COVID Countermeasure Development Contracts + Grants August 22, 2023 …
Bacterial and Viral Bioinformatics Resource Center Website Now Available Resources February 26, 2022 …
Bucknell Researchers Head to Uganda to Study African Bats’ Immune Response to Ebola Virus Biosecurity February 6, 2022 …
How Well Do Covid Vaccines Hold Up Over Time? Macaque Study Shows Decline in Lung Protection Biosecurity December 4, 2021 …
UTHSC Awarded $3.2 Million for Upgrades to Regional Biocontainment Laboratory Biosecurity October 5, 2021 …
Licensing Opportunity: Virus-Like Particle Technology for Universal Flu Vaccine Contracts + Grants July 13, 2021 …
RFI Supports Research on Impact of Nuclear Incident on the Microbiome and Development of Targeted Therapeutics CBRNE June 6, 2021 …
Nanoparticle Mosaic Quadrivalent Flu Vaccine Phase 1 Clinical Trial Gets Underway Medical Countermeasures June 1, 2021 …
2021 BAA for Development of Medical Countermeasures for Biological Threats Contracts + Grants March 2, 2021 …
Neutralizing Norovirus: NIAID Monoclonal Antibodies Licensing Opportunity Contracts + Grants November 25, 2020 …
